Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Preview

Firefly Neuroscience and Next Health launched a precision cognitive health platform integrating Firefly’s FDA-cleared AI-powered EEG/ERP brain biomarker technology with personalized cognitive peptide protocols. The initiative follows an FDA Advisory…